DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 37 filers reported holding DECIBEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $836,000 | -34.6% | 275,001 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $1,279,000 | -40.8% | 275,001 | -2.0% | 0.02% | -48.6% |
| Q3 2021 | $2,162,000 | -10.4% | 280,473 | -0.0% | 0.04% | -22.2% |
| Q2 2021 | $2,412,000 | -24.3% | 280,511 | 0.0% | 0.04% | -36.6% |
| Q1 2021 | $3,187,000 | – | 280,511 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $14,600,000 | 3.65% |
| Samsara BioCapital, LLC | 826,422 | $3,843,000 | 0.75% |
| Orbimed Advisors | 4,945,192 | $22,995,000 | 0.30% |
| Alphabet Inc. | 1,636,258 | $7,609,000 | 0.18% |
| Casdin Capital, LLC | 1,170,048 | $5,441,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,529,000 | 0.14% |
| Bronte Capital Management Pty Ltd. | 157,216 | $731,000 | 0.05% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $190,766,000 | 0.03% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $1,226,000 | 0.02% |
| Woodline Partners LP | 275,001 | $1,279,000 | 0.02% |